Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

RSS icon
Thumbnail

COVID-era telephone visits confer higher 90-day mortality risk for HF patients

According to a new analysis, the widespread use of remote heart failure care during the pandemic may lead to increased telemedicine use in the future. 

Thumbnail

Remote PA pressure monitoring pays off when treating HF patients

The study, published in Current Problems in Cardiology, included both a systematic review and a meta-analysis.

Thumbnail

Heart failure patients with cirrhosis more likely to be readmitted within 30 days

When hospitalized heart failure patients also have cirrhosis of the liver, they may require "increased resources to assist in caring for them."

Thumbnail

TEER benefits all HF patients with SMR, but men see more long-term benefits

The study's authors examined data from men and women who underwent TEER with the MitraClip device in addition to guideline-directed medical therapy. 

Thumbnail

Cancer shortens lifespan of organ transplant patients, especially those receiving a new lung or heart

Nearly 6% of transplant recipients developed cancer within 10 years of the procedure, researchers reported.

Thumbnail

Updated FDA policy could improve treatment for up to 1.8 million HF patients

Expanded FDA labeling for sacubitril/valsartan could make a massive impact on patient care in the next three years.

Thumbnail

Risk score predicts new‐onset HF among AFib patients in the ED

The study's authors hope their work can help high-risk patients receive the care they need. 

Thumbnail

Dapagliflozin significantly improves HFpEF symptoms

One researcher described the findings, presented at the Heart Failure Society of America's Annual Scientific Meeting, as "great news for patients and clinicians."

Displaying 337 - 344 of 673
Design by Adaptive Theme